U
rinary
EN-2
to
predict
prostate
cancer
: S
ystematic
review
and
meta
-
analysis
R
ev
A
ssoc
M
ed
B
ras
2017; 63(7):656-661
661
5.
Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate
cancer. Cochrane Database Syst Rev. 2013; (1):CD004720.
6.
Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, et al.
Mortality results from the Göteborg randomised population-based prostate-
cancer screening trial. Lancet Oncol. 2010; 11(8):725-32.
7.
Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, et al. Engrailed-2
(EN2): a tumor specific urinary biomarker for the early diagnosis of prostate
cancer. Clin Cancer Res. 2011; 17(5):1090-8.
8.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et
al. The PRISMA statement for reporting systematic reviews and meta-analysis
of studies that evaluate healthcare interventions: explanation and elaboration.
BMJ. 2009; 339:b2700.
9. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB,
et al.; Quadas-2 Group. Quadas-2: a revised tool for the quality assess-
ment of diagnostic accuracy studies. Ann Intern Med. 2011; 155(8):529-
36.
10. Altman DG. Some common problems in medical research. In: Altman DG,
editor. Practical statistics for medical research. 9. ed. London: Chapman;
1999. p. 396-439.
11.
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen:
The Nordic Cochrane Centre, The Cochrane Collaboration.
12. Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A. Meta-DiSc: a software
for meta-analysis of test accuracy data. BMCMed Res Methodol. 2006; 6:31.
13.
Killick E, Morgan R, Launchbury F, Bancroft E, Page E, Castro E, et al. Role
of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically
high risk men. Sci Rep. 2013; 3:2059.
14.
Pandha H, Sorensen KD, Orntoft TF, Langley S, Hoyer S, Borre M, et al. Uri-
nary engrailed-2 (EN2) levels predict tumour volume in men undergoing rad-
ical prostatectomy for prostate cancer. BJU Int. 2012; 110(6 Pt B ):287-92.
15.
Santos CL, Lamounier TAC. Aspectos clínicos e laboratoriais do câncer de
próstata [final paper]. Brasília: Curso de Biomedicina; Universidade Católica
de Brasília; 2013.